Breathe in your next COVID shot? new vaccine trial tests Lung-Targeting mist
NCT ID NCT06381739
Summary
This study is testing a new COVID-19 vaccine that you breathe in as a mist, aiming to trigger a stronger immune defense right in the lungs. It will involve 350 healthy adults who have already had three doses of an mRNA COVID vaccine. Researchers will compare the new inhaled vaccine to a placebo to check its safety and see if it creates a good immune response in the lungs and blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Canadian Center for Vaccinology, Dalhousie University
RECRUITINGHalifax, Nova Scotia, B3K 6R8, Canada
Contact
Contact Phone: •••-•••-••••
-
Health Sciences Centre
RECRUITINGHamilton, Ontario, L8S 4K1, Canada
Conditions
Explore the condition pages connected to this study.